350 related articles for article (PubMed ID: 29696556)
1. Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.
Tahani N; Nieddu L; Prossomariti G; Spaziani M; Granato S; Carlomagno F; Anzuini A; Lenzi A; Radicioni AF; Romagnoli E
Endocrine; 2018 Aug; 61(2):327-335. PubMed ID: 29696556
[TBL] [Abstract][Full Text] [Related]
2. The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study.
Willems S; David K; Decallonne B; Marcq P; Antonio L; Vanderschueren D
Andrology; 2023 Oct; 11(7):1295-1302. PubMed ID: 36792918
[TBL] [Abstract][Full Text] [Related]
3. Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome.
Vena W; Carrone F; Delbarba A; Akpojiyovbi O; Pezzaioli LC; Facondo P; Cappelli C; Leonardi L; Balzarini L; Farina D; Pizzocaro A; Lania AG; Mazziotti G; Ferlin A
J Endocrinol Invest; 2023 Feb; 46(2):297-304. PubMed ID: 36030302
[TBL] [Abstract][Full Text] [Related]
4. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and quantitative ultrasound parameters in patients with Klinefelter's syndrome after long-term testosterone substitution.
van den Bergh JP; Hermus AR; Spruyt AI; Sweep CG; Corstens FH; Smals AG
Osteoporos Int; 2001; 12(1):55-62. PubMed ID: 11305084
[TBL] [Abstract][Full Text] [Related]
6. Testosterone treatment in male patients with Klinefelter syndrome: a systematic review and meta-analysis.
Pizzocaro A; Vena W; Condorelli R; Radicioni A; Rastrelli G; Pasquali D; Selice R; Ferlin A; Foresta C; Jannini EA; Maggi M; Lenzi A; Pivonello R; Isidori AM; Garolla A; Francavilla S; Corona G;
J Endocrinol Invest; 2020 Dec; 43(12):1675-1687. PubMed ID: 32567016
[TBL] [Abstract][Full Text] [Related]
7. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
[TBL] [Abstract][Full Text] [Related]
8. Epicardial fat: the role of testosterone and lipid metabolism in a cohort of patients with Klinefelter syndrome.
Granato S; Barbaro G; Di Giorgio MR; Rossi FM; Marzano C; Impronta F; Spaziani M; Anzuini A; Lenzi A; Radicioni AF
Metabolism; 2019 Jun; 95():21-26. PubMed ID: 30878494
[TBL] [Abstract][Full Text] [Related]
9. Compromised Volumetric Bone Density and Microarchitecture in Men With Congenital Hypogonadotropic Hypogonadism.
Ostertag A; Papadakis GE; Collet C; Trabado S; Maione L; Pitteloud N; Bouligand J; De Vernejoul MC; Cohen-Solal M; Young J
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3312-e3326. PubMed ID: 33725720
[TBL] [Abstract][Full Text] [Related]
10. Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome.
Jo DG; Lee HS; Joo YM; Seo JT
Yonsei Med J; 2013 Nov; 54(6):1331-5. PubMed ID: 24142635
[TBL] [Abstract][Full Text] [Related]
11. Bone involvement in males with Kallmann disease.
Iolascon G; Frizzi L; Bianco M; Gimigliano F; Palumbo V; Sinisi AM; Sinisi AA
Aging Clin Exp Res; 2015 Oct; 27 Suppl 1():S31-6. PubMed ID: 26201943
[TBL] [Abstract][Full Text] [Related]
12. Chronic hemodialysis is associated with lower trabecular bone score, independent of bone mineral density: a case-control study.
Dusceac R; Niculescu DA; Dobre R; Dragne MC; Tacu C; Peride I; David C; Checherita I; Poiana C
Arch Osteoporos; 2018 Nov; 13(1):125. PubMed ID: 30426286
[TBL] [Abstract][Full Text] [Related]
13. Mild Deficits of Cortical Bone in Young Adults With Klinefelter Syndrome or Anorchia Treated With Testosterone.
Wong SC; Scott D; Lim A; Tandon S; Ebeling PR; Zacharin M
J Clin Endocrinol Metab; 2015 Sep; 100(9):3581-9. PubMed ID: 26186297
[TBL] [Abstract][Full Text] [Related]
14. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
[TBL] [Abstract][Full Text] [Related]
15. Trabecular bone score as a skeletal fragility index in acromegaly patients.
Hong AR; Kim JH; Kim SW; Kim SY; Shin CS
Osteoporos Int; 2016 Mar; 27(3):1123-1129. PubMed ID: 26446771
[TBL] [Abstract][Full Text] [Related]
16. Testosterone Replacement Therapy in Klinefelter Syndrome-Follow-up Study Associating Hemostasis and RNA Expression.
Chang S; Just J; Skakkebæk A; Johannsen EB; Fedder J; Gravholt CH; Münster AB
J Clin Endocrinol Metab; 2024 Mar; 109(4):978-991. PubMed ID: 37962976
[TBL] [Abstract][Full Text] [Related]
17. The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
Papadakis G; Hans D; Gonzalez-Rodriguez E; Vollenweider P; Waeber G; Marques-Vidal PM; Lamy O
J Clin Endocrinol Metab; 2016 Dec; 101(12):5004-5011. PubMed ID: 27854548
[TBL] [Abstract][Full Text] [Related]
18. Bone mass in subjects with Klinefelter syndrome: role of testosterone levels and androgen receptor gene CAG polymorphism.
Ferlin A; Schipilliti M; Vinanzi C; Garolla A; Di Mambro A; Selice R; Lenzi A; Foresta C
J Clin Endocrinol Metab; 2011 Apr; 96(4):E739-45. PubMed ID: 21270324
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone.
Bojesen A; Birkebæk N; Kristensen K; Heickendorff L; Mosekilde L; Christiansen JS; Gravholt CH
Osteoporos Int; 2011 May; 22(5):1441-50. PubMed ID: 20658127
[TBL] [Abstract][Full Text] [Related]
20. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism.
Eller-Vainicher C; Filopanti M; Palmieri S; Ulivieri FM; Morelli V; Zhukouskaya VV; Cairoli E; Pino R; Naccarato A; Verga U; Scillitani A; Beck-Peccoz P; Chiodini I
Eur J Endocrinol; 2013 Aug; 169(2):155-62. PubMed ID: 23682095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
